Therapeutic efficacy of single-dose iso-[211At]SAGMB-anti-HER2 sdAb in mice with subcutaneous HER2-expressing breast carcinoma xenografts
Publication
, Conference
Feng, Y; Jannetti, S; Meshaw, R; Vaidyanathan, G; Zalutsky, M
Published in: JOURNAL OF NUCLEAR MEDICINE
2021
Duke Scholars
Published In
JOURNAL OF NUCLEAR MEDICINE
EISSN
1535-5667
ISSN
0161-5505
Publication Date
2021
Volume
62
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Feng, Y., Jannetti, S., Meshaw, R., Vaidyanathan, G., & Zalutsky, M. (2021). Therapeutic efficacy of single-dose iso-[211At]SAGMB-anti-HER2 sdAb in mice with subcutaneous HER2-expressing breast carcinoma xenografts. In JOURNAL OF NUCLEAR MEDICINE (Vol. 62).
Feng, Yutian, Stephen Jannetti, Rebecca Meshaw, Ganesan Vaidyanathan, and Michael Zalutsky. “Therapeutic efficacy of single-dose iso-[211At]SAGMB-anti-HER2 sdAb in mice with subcutaneous HER2-expressing breast carcinoma xenografts.” In JOURNAL OF NUCLEAR MEDICINE, Vol. 62, 2021.
Feng Y, Jannetti S, Meshaw R, Vaidyanathan G, Zalutsky M. Therapeutic efficacy of single-dose iso-[211At]SAGMB-anti-HER2 sdAb in mice with subcutaneous HER2-expressing breast carcinoma xenografts. In: JOURNAL OF NUCLEAR MEDICINE. 2021.
Feng, Yutian, et al. “Therapeutic efficacy of single-dose iso-[211At]SAGMB-anti-HER2 sdAb in mice with subcutaneous HER2-expressing breast carcinoma xenografts.” JOURNAL OF NUCLEAR MEDICINE, vol. 62, 2021.
Feng Y, Jannetti S, Meshaw R, Vaidyanathan G, Zalutsky M. Therapeutic efficacy of single-dose iso-[211At]SAGMB-anti-HER2 sdAb in mice with subcutaneous HER2-expressing breast carcinoma xenografts. JOURNAL OF NUCLEAR MEDICINE. 2021.
Published In
JOURNAL OF NUCLEAR MEDICINE
EISSN
1535-5667
ISSN
0161-5505
Publication Date
2021
Volume
62
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences